Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious disease

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 116-123

  Cabral, Guy A ^a   Dove Pettit, Denise A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoids; Delta 9 tetrahydrocannabinol; Drugs and immunity; Herpes simplex virus; Marijuana

Indexed keywords

CANNABINOID; CANNABIS; DRONABINOL;

ARTICLE; BACTERIAL INFECTION; CELLULAR IMMUNITY; HUMAN; IMMUNE DEFICIENCY; INFECTION RESISTANCE; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; CANNABINOIDS; HUMANS; IMMUNE SYSTEM; SUBSTANCE-RELATED DISORDERS; VIRUS DISEASES;

EID: 0344505201     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00227-0     Document Type: Article

References (57)

1. Arata S., Newton C., Klein T., Friedman H. Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages. Proc. Soc. Exp. Biol. Med. 199(1):1992;65-67.
2. Baczynsky W.O.T., Zimmerman A.M. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. In vitro investigation using cultured mouse splenocytes. Pharmacology. 26(1):1983;12-19.
3. Burnette-Curley D., Marciano-Cabral F., Fischer-Stenger K., Cabral G.A. Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmétte-Guérin-activated macrophages. Int. J. Immunopharmacol. 15:1993;371-382.
4. Cabral G.A., Mishkin E.M., Marciano-Cabral F., Coleman P., Harris L., Munson A.E. Effect of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc. Soc. Exp. Biol. Med. 182:1986;181-186.
5. Cabral G.A., Lockmuller J.C., Mishkin E.M. Delta-9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc. Soc. Exp. Biol. Med. 181:1986;305-311.
6. Cabral G.A., Vásquez R. Marijuana decreases macrophage anti-viral and anti-tumor activities. Adv. Biosci. 80:1991;93-105.
7. Cabral, G.A., Vásquez, R., 1991b. Effects of marijuana on macrophage function. In: Friedman, H., Specter, S., Klein, T. (Eds.), Drugs of Abuse, Immunity, and Immunodeficiency. Plenum, New York, pp. 93-105.
8. Cabral, G.A., Vásquez, R., 1992. Delta-9-tetrahydrocannabinol suppresses macrophage extrinsic anti-herpesvirus activity. In: Nahas, G.C., Latour, C. (Eds.), Cannabis: Physiopathology, Epidemiology, Detection. CRC Press, Boca Raton, FL, pp. 137-153.
9. Cushman P., Khurana R. Marijuana and T lymphocyte rosettes. Clin. Pharmacol. Ther. 19:1976;310-317.
10. Cushman P. Jr., Khurana R. A controlled cycle of tetrahydrocannabinol smoking: T and B cell rosette formation. Life Sci. 20:1977;971-980.
11. Dewey W.L. Cannabinoid pharmacology. Pharmacol. Rev. 38(2):1986;151-178.
12. Felder C.C., Veluz J.S., Williams H.L., Briley E.M., Matsuda L.A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:1992;838-845.
13. Fischer-Stenger K., Updegrove A.W., Cabral G.A. Delta-9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proc. Soc. Exp. Biol. Med. 200:1992;422-430.
14. Fischer-Stenger K., Dove Pettit D.A., Cabral G.A. Delta-9-tetrahydrocannabinol inhibition of tumor necrosis factor-α: suppression of post-translational events. J. Pharmacol. Exp. Ther. 267:1993;1558-1565.
15. Gross G., Roussaki A., Ikenberg H., Drees N. Genital warts do not respond to systemic recombinant interferon alpha-2a treatment during cannabis consumption. Dermatology. 183:1991;203-207.
16. Houston D.B., Howlett A.C. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. Mol. Pharmacol. 43:1993;17-22.
17. Howlett A.C., Champion T.M., Wilken G.H., Mechoulam R. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenyl cyclase and bind to the cannabinoid receptor. Neuropharmacology. 29:1990;161-165.
18. Juel-Jensen B.E. Cannabis and recurrent herpes simplex. Br. Med. J. 4:1972;296.
19. Kaklamani E., Trichopoulos D., Koutselinis A., Drouga M., Karalis D. Hashish smoking and T-lymphocytes. Arch. Toxicol. 40:1978;97-101.
20. Klaassen, C.D., Doull, J., 1980. Evaluation of safety. Toxicologic evaluation. In: Doull, J., Klaassen, C.D., Amdur, M.O. (Eds.), Toxicology: The Basic Science of Poisons. Macmillan, New York, p. 11.
21. Klein T.W., Newton C., Widen R., Friedman H. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta 9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses. J. Immunopharmacol. 7:1985;451-466.
22. Klein T.W., Newton C., Friedman H. Inhibition of natural killer cell function by marijuana components. J. Toxicol. Environ. Health. 20:1987;321-332.
23. Klein T.W., Newton C., Widen R., Friedman H. Delta-9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267(2):1993;635-640.
24. Klykken P.C., Smith S.H., Levy J.A., Razdan R., Munson A.E. Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC). J. Pharmacol. Exp. Ther. 201:1977;573-579.
25. Lau R.J., Tubergen D.G., Barr M. Jr., Domino E.F., Benowitz N., Jones R.T. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta-9-tetrahydrocannabinol. Science. 192:1976;805-807.
26. Lawman M.J.P., Rouse B.T., Courtney R.J., Walker R.D. Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect. Immun. 27:1980;133-139.
27. Lopez-Cepero M., Friedman M., Klein T., Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocyte activity in vitro. J. Leukocyte Biol. 39:1986;679-686.
28. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA. 89:1992;3825-3829.
29. Marciano-Cabral F. Biology of Naegleria spp. Microbiol. Rev. 52:1988;114-133.
30. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
31. McKendall R.R., Klassen T., Baringer J.R. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect. Immun. 23:1979;305-311.
32. 1 mouse. J. Gen. Virol. 66:1985;2539-2549.
33. Morahan P.S., Breinig M.C., McGeorge M.B. Immune responses to vaginal or systemic infection of BALBc mice with herpes simplex virus type 2. J. Immunol. 119:1977;2030-2036.
34. Morahan P.S., Glasgow L.A., Crane J.L. Jr., Kern E.R. Comparison of anti-viral and anti-tumor activity of activated macrophages. Cell. Immunol. 28:1977;404-415.
35. Morahan P.S., Klykken P.C., Smith S.H., Harris L.S., Munson A.E. Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23:1979;670-674.
36. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
37. Munson, A.E., Fehr, K.O., 1983. Immunological effects of cannabis. In: Fehr, K.O., Kalant, H. (Eds.), Cannabis and Health Hazards. Alcoholism and Drug Addiction Research Foundation, Toronto, pp. 257-353.
38. Munson, A.E., Levy, J.A., Harris, L.S. Dewey, W.L., 1976. Effects of delta 9-tetrahydrocannabinol on the immune system. In: Braude, M.C., Szara, S. (Eds.), The Pharmacology Of Marijuana. Raven Press, New York, pp. 187-197.
39. Nahas G., Latour C. The human toxicity of marijuana. Med. J. Aust. 156(7):1992;495-497.
40. Nahas G.G., Osserman E.F. Altered serum immunoglobulin concentration in chronic marijuana smokers. Adv. Exp. Med. Biol. 288:1991;25-32.
41. Nahas G.G., Suciu-Foca N., Armand J.P., Morishima A. Inhibition of cellular mediated immunity in marijuana smokers. Science. 183:1974;419-420.
42. Nakano Y., Pross S.H., Friedman H. Modulation of interleukin 2 activity by delta-9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody. Proc. Soc. Exp. Biol. Med. 20:1992;165-168.
43. Nash A.A., Cambouropoulos P. The immune response to herpes simplex virus. Semin. Virol. 4:1993;181-186.
44. Rachelefsky G.S., Opelz G. Normal lymphocyte function in the presence of delta-9-tetrahydrocannabinol. Clin. Pharmacol. Ther. 21:1977;44-46.
45. Selgrade M.K., Osborn J.E. Role of macrophages in resistance to murine cytomegalovirus. Infect. Immun. 10:1974;1383-1390.
46. Sethi K.K., Brandis H. Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 and 2. Immunobiology. 153:1977;162-173.
47. Smith S.H., Harris L.S., Uwaydah I.M., Munson A.E. Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J. Pharmacol. Exp. Ther. 207:1978;165-170.
48. Specter S.C., Klein T.W., Newton C., Mondragon M., Widen R., Friedman H. Marijuana effects on immunity:suppression of human natural killer cell activity by delta-9-tetrahydrocannabinol. Int. J. Immunopharmacol. 8:1986;741-745.
49. Specter S.C., Lancz G., Westrich G., Friedman H. Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. 13(4):1991;411-417.
50. Stevens J.G., Cook M.L. Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus integration. J. Exp. Med. 133:1971;19-38.
51. Tennant F.S. Jr., Groesbeck C.J. Psychiatric effects of hashish. Arch. Gen. Psych. 27:1972;133-136.
52. Tindall B., Cooper D.A., Donovan B., Barnes T., Philpot C.R., Gold J., Penny R. The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust. N.Z. J. Med. 18(1):1988;8-15.
53. Turner C.E., Elsohly M.A., Boeren E.G. Constituents of Cannabis sativa L.: XVII. A review of the natural constituents. J. Nat. Prod. 43:1980;169-234.
54. Watzl B., Scuderi P., Watson R.R. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1-alpha in vitro. Int. J. Immunopharmacol. 13:1991;1091-1097.
55. Wing, D.R., Leuschner, J.T.A., Brent, G.A., Harvey, D.J., Paton, W.D.M., 1985. Quantification of in vivo membrane associated delta-9-tetrahydrocannabinol and its effects on membrane fluidity. In: Harvey, D.J. (Ed.), Proceedings of the 9th International Congress of Pharmacology 3rd Satellite Symposium on Cannabis. IRL Press, Oxford, pp. 411-418.
56. Zheng Z.-M., Specter S., Friedman H. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol. 14:1992;1445-1452.
57. Zinkernagel R.M., Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature. 248:1974;701-702.